Univariate analysis | ||
---|---|---|
HR [95%CI] | p | |
Age at diagnosis (> vs. ≤ 65 years) | 2.13 [0.81;5.61] | 0.12 |
Gender (male/female) | 0.52 [0.16;3.07] | 0.30 |
T stage (T3/T4 vs. T1/T2) | 5.44 [1.36;16.48] | 0.007 |
Nodal status (positive/negative) | 1.34 [0.49;3.63] | 0.56 |
Clinical stage (IIIA/IIIB vs. I/II) | 2.72 [0.78;9.46] | 0.12 |
Chemotherapy associated with radiation therapy (yes/no) | 0.79 [0.28;2.27] | 0.67 |
CYFRA 21-1 levels (elevated /normal) | ||
Pre-treatment | 5.99 [0.80;45.22] | 0.08 |
Post-treatment | 4.05 [1.49;10.95] | 0.006 |